A behavioral-health group we worked with hit the ceiling of their practice management software at around the fourth location. The tool that felt perfect for a solo therapist now needed six workarounds, three exported spreadsheets, and a standing Friday meeting just to reconcile billing. Their question was the one every growing practice eventually asks — mental health practice management software build vs buy: do we keep licensing, or do we build? The most useful answer we gave them wasn't build or buy. For most practices weighing behavioral-health software, the real move is buy the core, then build around it — and knowing which parts to build is the whole game.
Mental health practice management software build vs. buy is the decision between licensing a ready-made platform (SimplePractice, TherapyNotes, Valant) and commissioning a custom system tailored to your workflow. Both are legitimate. Choosing well starts with an honest look at what the decision is actually costing you today.
Before comparing options, price the pain — because the "do nothing / just keep buying" path has a cost that rarely shows up on an invoice.
Three numbers make the case. First, documentation burden: clinicians spend roughly two hours on paperwork for every hour of patient care, and about 78% of EHR time goes to note-writing — the leading driver of a burnout rate that hit 41.9% of physicians reporting at least one symptom in 2025 (Tebra, Barton Associates). Second, no-shows: mental-health no-show rates run 18–25%, sometimes as high as 50% — roughly double primary care (Curogram). Every missed slot is revenue that a better reminder-and-scheduling workflow could have saved. Third, denials: a KFF survey found 22% of insured adults who used mental-health services had a claim denied, and fewer than 1% of denials are ever appealed (KFF). Behavioral-health initial denial rates commonly land in the 15–25% range, driven mostly by medical-necessity and documentation issues (Core Solutions).
Whatever you choose, it has to move those three numbers. That's the yardstick.
For most practices, off-the-shelf software is the right starting point, and the market reflects it — the US behavioral-health software and services market reached $1.49 billion in 2024 and is growing at 12.5% a year (Grand View Research). These platforms cover the standard outpatient workflow — scheduling, notes, telehealth, billing — out of the box, and they go live in days, not months.
The therapy-native landscape sorts roughly by size and price:
Platform | Best fit | Rough pricing |
TheraNest / Ensora | Budget-conscious small practices | From ~$29/mo |
SimplePractice | Solo to small groups, polished UX + mobile | ~$49–$99/mo solo; groups from ~$158/mo |
TherapyNotes | Documentation-heavy practices | ~$49/mo solo; groups $59 + $30/added clinician |
ICANotes | Prescribers, deep note templates | <$100/mo non-prescriber |
Valant | Multi-team, analytics + measurement-based care | Per-provider |
Tebra / AdvancedMD | Billing/RCM-first, all-in-one | Per-provider, climbs with modules |
(Pricing is public-list and shifts; verify current tiers before deciding.)
If a therapy-native platform covers 80%+ of how you actually work, buy it and move on. Building what SimplePractice already does well is a waste of capital.
Custom earns its place when the standard workflow isn't your workflow. The signals we look for:
Non-standard clinical programs — intensive outpatient (IOP), partial hospitalization (PHP), group therapy, or measurement-based care that SaaS models awkwardly or not at all.
Integration sprawl — you're re-keying data between your EHR, billing/clearinghouse, telehealth, and eligibility tools because the SaaS integrations are fixed and don't reach your stack. This is where systems integration and EHR integration usually pay for themselves.
Multi-location scale — per-provider SaaS pricing climbs relentlessly; past a certain headcount, custom economics flip in your favor.
Data ownership and lock-in — you want to own your data, audit trails, and roadmap rather than rent them.
Building isn't cheaper upfront. It's cheaper at scale, and it's the only path when the software has to bend to a workflow the market doesn't sell.
Here's the position we hold after doing this work: pure build-from-scratch is rarely the right answer, and neither is suffering inside a SaaS box you've outgrown. Keep a commercial EHR/PMS core for the commodity work — notes, standard billing, the parts every practice does the same way — and build the differentiated layer around it: a custom patient portal, a measurement-based-care dashboard, intake automation, eligibility checks, or a reporting layer your commercial tool can't produce.
This is the same logic behind any good build-vs-buy decision: don't rebuild the commodity, build the differentiator. It gets you fast go-live on the boring 80% and custom leverage on the 20% that actually distinguishes your practice — without betting the whole operation on a ground-up build.
Behavioral health carries a compliance weight general medical software doesn't, and it directly shapes the build-vs-buy math. HIPAA is the floor. The harder requirement is 42 CFR Part 2, which governs substance-use-disorder records with stricter, element-level consent and segmented-disclosure rules — and its updated final rule carried a compliance date of February 16, 2026 (OptiMantra).
This matters for the decision because most general SaaS platforms handle Part 2 consent bluntly, if at all. If you treat SUD, granular consent enforcement may be exactly the thing you have to build — a point we unpack in 42 CFR Part 2-compliant development. Compliance can be the single factor that tips a practice from "buy" to "buy plus build."
Run your practice through four questions:
Does a therapy-native platform cover 80%+ of your workflow? If yes, buy — and stop reading.
Are you re-keying data across three or more systems? If yes, you have an integration problem custom work solves better than switching SaaS.
Do you run non-standard programs or treat SUD? If yes, plan to build around a core, not to force-fit a box.
Is per-seat pricing outpacing your growth? If yes, model the crossover point where custom gets cheaper.
Most growing practices land in the same place: buy the core, build the edges, and get the compliance layer right. If you want help drawing that line for your practice, book a free consultation — we'll tell you honestly when not to build.
The build-vs-buy question is really a what to build question. Buy the commodity, build the differentiator, and make sure whatever you choose moves your no-show, documentation, and denial numbers. Off-the-shelf is the right start for most practices; the ceiling arrives with scale, integration sprawl, and Part 2 requirements. When it does, a hybrid gives you the speed of SaaS and the leverage of custom without betting the practice on either extreme.
By the CodeStringers Team — Zoho Experts & Custom Software. CodeStringers is a custom software engineering firm with a dedicated behavioral-health practice, writing from work we've actually shipped for clients.
In a no-risk discovery we look at your CRM, finance and operations systems and who owns each part, and show what a connected system would do differently. You pay only if you proceed. Or see how we approach it.
More on the same problem:
Appointment Scheduling Software for Mental Health Practices: What to Look For (article)
A Build vs Buy Analysis Framework (Stop Asking the Wrong Question) (article)
Custom Inventory Management Software for Manufacturers: When to Build Instead of Buy (article)
Off-the-shelf platforms are priced per clinician per month, with solo plans at the low end and group plans adding a per-clinician fee, and prices climb as billing, telehealth and analytics modules are added. A custom build costs more up front, usually a project fee plus ongoing maintenance, but does not scale with headcount. The crossover point depends on the number of clinicians and how many systems need to be connected, which is why the decision deserves a three-year model.
A full replacement of a commercial platform is a long project and rarely the right one. The hybrid path is faster: keep the commercial core for notes and standard billing, and build the differentiated layer, such as a patient portal, an intake flow, a measurement dashboard or a reporting layer. Each of those is a project measured in months rather than years, and each can go live separately while the practice keeps running on its existing tools.
Staff re-key data between the EHR, billing, telehealth and eligibility tools. Reconciling billing needs a standing meeting and exported spreadsheets. Programs such as intensive outpatient, partial hospitalization or group therapy do not fit the platform's model. Per-provider pricing is rising faster than revenue. And substance use consent rules are handled bluntly or not at all. Any two of those together usually mean the fix is integration or a built layer rather than another platform switch.
Only if the practice treats substance use disorders, but then it matters a great deal. Part 2 governs substance use treatment records with stricter, element-level consent and segmented disclosure rules than HIPAA, and the updated final rule carried a compliance date of February 16, 2026. Most general platforms handle Part 2 consent bluntly, if at all. For practices treating SUD, granular consent enforcement is often the one feature they have to build around a bought core.
The parts that distinguish the practice, not the parts every practice does the same way. Notes and standard billing are commodity and belong in a commercial core. A custom patient portal, intake automation, eligibility checks, a measurement based care dashboard, Part 2 consent handling and reporting the commercial tool cannot produce are the usual candidates. The rule is to buy the commodity and build the differentiator, then make sure whatever is chosen moves no-show, documentation and denial numbers.
"Something isn't working." "We're outgrowing our tools." "We're afraid to make the wrong move." No-Risk Discovery is a short, practical conversation that gets you clarity before you commit to anything big. We'll tell you if we're a fit. If we're not, we'll tell you that too.
Say who you are and ask. A person replies within one business day.
